1
|
Retinoblastoma in Sweden. A study of 45 children with retinoblastoma with special regard to the therapeutical results. Acta Ophthalmol 2009; 51:543-50. [PMID: 4800981 DOI: 10.1111/j.1755-3768.1973.tb06033.x] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
|
2
|
Abstract
OBJECTIVE To describe the visual field defects in retinoblastoma survivors and relate those defects to characteristics such as tumor size, tumor location, and treatment modality. METHODS Thirty-one patients treated for retinoblastoma were included in this study. Humphrey visual fields were determined in 33 eyes. RESULTS Twenty-seven patients (29 eyes, 68 tumors) had sufficient diagnosis and treatment data available for further analysis. Twenty-six of the 27 patients had both absolute and relative visual field defects. Four types of visual field defects were observed and correlated with location of the tumor and therapy to the individual tumors: (1) no residual defect, (2) absolute scotoma, (3) arcuate and sector scotoma, and (4) "pseudo"-visual field defects caused by relative enophthalmos resulting from radiation. CONCLUSIONS Patients with retinoblastoma demonstrate a variety of long-term visual field defects after treatment for their intraocular disease. Characteristics that determine the size and type of defects are tumor size, tumor location, and treatment method.
Collapse
|
3
|
Abstract
The objective of this study was to assess the role of various clinical and treatment factors involved in the long-term incidence of nonocular second primary tumors following retinoblastoma. The study was based on 111 patients treated between 1963 and 1977 according to the same radiotherapy protocol (electron beam radiotherapy) alone or in combination with triethylene melamine (TEM). Various statistical methods were used to obtain the actuarial survival curve, the cumulative incidence of second primary tumors, and comparisons of patient groups and subgroups. The 5-, 10-, 20-, and 30-year survival rates were 75%, 70%, 63%, and 55% with a follow-up of 23 to 35 years. The study reports the various parameters concerning 111 children and 17 second primary tumors: sex, age at treatment, histology of the retinoblastoma and second primary tumors, site of second tumors (anatomic and compared with irradiation field), radiation dose, time to onset, and chemotherapy with or without TEM. The results are discussed and compared with the data reported in the literature. Electron beam radiotherapy at a dose of 45 Gy does not eliminate the risk of nonocular second primary tumors. TEM also does not modify survival or the overall incidence of second primary tumors, but significantly increases the risk of second primary tumors outside the irradiation field.
Collapse
|
4
|
|
5
|
|
6
|
[Apropos of a case of renal oncocytoma with hepatic localization]. ANNALES D'UROLOGIE 1984; 18:415-7. [PMID: 6532315] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
Abstract
A renal oncocytoma was treated by radical nephrectomy. Although it was considered benign, hepatic localizations were discovered seven years later. The authors discuss the problems of whether these were secondary metastatic lesions or a new development in the evolution of the disease.
Collapse
|
7
|
Abstract
A high percentage of children with Wilms' tumor are cured with multimodal treatment. A small percentage of these children will develop second tumors, perhaps related to a genetic predisposition to neoplasia or possibly secondary to the treatment utilized for Wilms' tumor. Malignant mesothelioma has been associated with contact with asbestos but has also been reported after radiation exposure. Two patients are reported who developed malignant mesothelioma of the pleura after treatment for Wilms' tumor in childhood. Both received orthovoltage radiation; one patient also received triethylenemelamine (TEM), an alkylating agent closely related to nitrogen mustard, for 5 years. Factors in the development of second tumors are discussed.
Collapse
|
8
|
Abstract
Immediate and late results of treatment in 132 cases with bilateral retinoblastoma (the children were aged between two months and six years) were analyzed. Combined treatment comprised enucleation of the more affected eye, further chemotherapy, X-ray treatment and photocoagulation. Cytostatic compounds used were "TET" (analogous to "TEM") and "Prospidin". Of the treated children, 44.8% are alive; the period of observation ranged from seven to 16 years.
Collapse
|
9
|
Retinoblastoma. A survivor 12 years after treatment for metastatic disease. ARCHIVES OF OPHTHALMOLOGY (CHICAGO, ILL. : 1960) 1980; 98:711-3. [PMID: 7369906 DOI: 10.1001/archopht.1980.01020030705011] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
Abstract
A 21-year-old man currently is well 12 years after his last treatment for metastatic retinoblastoma.
Collapse
|
10
|
[Screening test of tumor potency of chemicals against sarcoma 180 ascites tumor cells (author's transl)]. IGAKU KENKYU. ACTA MEDICA 1978; 48:256-66. [PMID: 716808] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
|
11
|
Chemotherapy of childhood medulloblastoma. AMERICAN JOURNAL OF DISEASES OF CHILDREN (1960) 1976; 130:639-42. [PMID: 937282 DOI: 10.1001/archpedi.1976.02120070065013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
A number of chemotherapeutic agents have been shown to have anti-tumor activity against childhood medulloblastoma. Ten-year survival with optimal surgery and radiation therapy ranges from 5% to 25%. Carefully controlled clinical trials utilizing a combination of surgery, radiation therapy, and chemotherapy should be employed in the early stages of the disease in an attempt to define which drugs are most effective, and to improve the survival rate.
Collapse
|
12
|
[Remote results of combined treatment of retinoblastomas in children]. Vestn Oftalmol 1975:41-5. [PMID: 1224477] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
|
13
|
Non-Hodgkin's malignant lymphomata in adults: chemo-radiotherapy in stages III and IV. THE BRITISH JOURNAL OF CANCER. SUPPLEMENT 1975; 2:505-11. [PMID: 52369 PMCID: PMC2149580] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Patients presenting with Stage III or IV non-Hodgkin's malignant lymphoma were given chemotherapy; about 20% complete remission was obtained for both stages. The addition of radiotherapy increased the incidence to 70% in Stage III patients. The duration of first complete remission was longer for Stage III (25% of the patients are still in first remission at 7 years) than for Stage IV (0%). The survival was longer for nodular lymphosarcoma patients (25% are alive at 7 years for Stages III and IV) than for diffuse lymphosarcomata and reticulosarcomata (10%). Among the new drugs, VM 26 is able to produce a good frequency of remission in patients in relapse.
Collapse
|
14
|
Treatment of Sezary syndrome. Mayo Clin Proc 1974; 49:590-2. [PMID: 4277748] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
|
15
|
[Possibilities of conservative treatment of retinal tumors]. ARCHIVES D'OPHTALMOLOGIE ET REVUE GENERALE D'OPHTALMOLOGIE 1972; 32:879-83. [PMID: 4267720] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
|
16
|
[Cytostatic therapy of lymphogranulomatosis]. ZEITSCHRIFT FUR DIE GESAMTE INNERE MEDIZIN UND IHRE GRENZGEBIETE 1972; 27:1035-9. [PMID: 4123386] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
|
17
|
An attempt at selective chemotherapy of hypoxic cells: triethylenemelamine and irradiation of a C3H mouse mammary tumour. Eur J Cancer 1972; 8:501-7. [PMID: 4651785 DOI: 10.1016/0014-2964(72)90101-6] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
|
18
|
Radiation therapy in retinoblastoma. STRAHLENTHERAPIE 1972; 143:371-6. [PMID: 5048772] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
|
19
|
[Kaposi's sarcoma in children]. MONATSSCHRIFT FUR KINDERHEILKUNDE 1972; 120:81-4. [PMID: 4553107] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
|
20
|
|
21
|
Treatment of retinoblastoma. THE AMERICAN JOURNAL OF ROENTGENOLOGY, RADIUM THERAPY, AND NUCLEAR MEDICINE 1972; 114:16-23. [PMID: 4621576] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
|
22
|
[Distribution of free amino acids in plasma in patients with a chronic lymphatic and acute leukemia]. Wien Klin Wochenschr 1971; 83:245-8. [PMID: 5283980] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
|
23
|
MESH Headings
- Adult
- Aged
- Chlorambucil/therapeutic use
- Female
- Humans
- Leukemia, Lymphoid/blood
- Leukemia, Lymphoid/complications
- Leukemia, Lymphoid/diagnosis
- Leukemia, Lymphoid/drug therapy
- Leukemia, Lymphoid/physiopathology
- Leukocyte Count
- Lymphocytes
- Lymphoma, Non-Hodgkin/blood
- Lymphoma, Non-Hodgkin/complications
- Lymphoma, Non-Hodgkin/diagnosis
- Lymphoma, Non-Hodgkin/physiopathology
- Male
- Middle Aged
- Neoplasm Regression, Spontaneous
- Splenomegaly/complications
- Triethylenemelamine/therapeutic use
Collapse
|
24
|
Nonhormonal chemotherapy of tumors metastatic to bone. Clin Orthop Relat Res 1970; 73:64-72. [PMID: 4320328] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
|
25
|
[Therapeutic trial in disseminated Hodgkin's disease (stages 3 and IV) by sequence chemotherapy, radiotherapy, eventually associated with splenectomy and supplementary chemotherapy]. NOUVELLE REVUE FRANCAISE D'HEMATOLOGIE 1970; 10:597-608. [PMID: 4250282] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
|
26
|
[Duration of survival in chronic lymphocytic leukemia (study of 336 cases by an acturarial method]. NOUVELLE REVUE FRANCAISE D'HEMATOLOGIE 1970; 10:552-9. [PMID: 4250532] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
|
27
|
[Progress in the therapy of leukoses]. Wien Med Wochenschr 1970; 120:441-3. [PMID: 5286401] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
|
28
|
Prognosis in Hodgkin's disease with special reference to histologic type. Results of treatment predominantly by cytostatics. ACTA RADIOLOGICA: THERAPY, PHYSICS, BIOLOGY 1970; 9:81-101. [PMID: 4192443 DOI: 10.3109/02841867009129092] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
|
29
|
The treatment of chronic lymphocytic leukemia. Semin Hematol 1969; 6:344-56. [PMID: 4900651] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
|
30
|
|
31
|
Transplantable mouse plasma cell tumors in experimental chemotherapy. J Natl Cancer Inst 1969; 43:123-31. [PMID: 5816022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023] Open
|
32
|
|
33
|
Combination therapy in retinoblastoma. A 15-year summary of methods and results. ARCHIVES OF OPHTHALMOLOGY (CHICAGO, ILL. : 1960) 1968; 80:744-6. [PMID: 5699326 DOI: 10.1001/archopht.1968.00980050746012] [Citation(s) in RCA: 26] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
|
34
|
Chemotherapy of induced skin tumors in mice. GAN 1968; 59:367-76. [PMID: 4179170] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
|
35
|
|
36
|
|
37
|
Chemotherapy in polycythemia vera. ACTA GENETICAE MEDICAE ET GEMELLOLOGIAE 1968; 17:292-302. [PMID: 5241850 DOI: 10.1017/s1120962300026548] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
Abstract
Summary210 cases of polycythemia vera were observed over a period of 15 years. The majority of them received P32; treatment with Myleran instead of with radioactive phosphorus was instituted only recently. To a small number of patients chemotherapy was given alternately with P32. The differing response pattern to either kind of treatment and the possible interference of therapy with the natural development of the disease process are demonstrated in a few selected cases.
Collapse
|
38
|
|
39
|
[Autoimmune hemolytic anemia and as a result of x-ray and cytostatic treatment in lymphatic leukemia]. ALLERGIE UND ASTHMA 1967; 13:264-6. [PMID: 5601333] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|
40
|
[Long-term survivals in lymphomas and generalized lymphosarcomas treated by chemo- and hormonal therapy]. SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT 1967; 97:1478-9. [PMID: 5631771] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
|
41
|
[Desired and undesirable effects of cytostatic therapy]. MEDIZINISCHE KLINIK 1967; 62:1653-9. [PMID: 5594047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|
42
|
[Chemotherapy of chronic lymphocytic leukemia]. MEDIZINISCHE KLINIK 1967; 62:1237-9. [PMID: 4969643] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
|
43
|
II. Medulloblastoma. Therapy with triethylene melamine and cobalt 60 irradiation. BULLETIN OF THE LOS ANGELES NEUROLOGICAL SOCIETIES 1967; 32:161-8 contd. [PMID: 6035964] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
|
44
|
[Association of intralymphatic radiotherapy and alkylating agents in the treatment of retroperitoneal hematosarcomas]. NOUVELLE REVUE FRANCAISE D'HEMATOLOGIE 1967; 7:381-92. [PMID: 4229322] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
|
45
|
Pipobroman (Vercyte) - a new antineoplastic drug. THE MEDICAL LETTER ON DRUGS AND THERAPEUTICS 1967; 9:27. [PMID: 5298493] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
|
46
|
[Combinations and sequences of multiple chemotherapeutic compounds in leukemia and hematosarcoma]. SEMAINE THERAPEUTIQUE 1966; 42:580-2. [PMID: 5996655] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
|
47
|
[Trial treatment of generalized Hodgkin's disease by multiple chemotherapy]. LA SEMAINE DES HOPITAUX : ORGANE FONDE PAR L'ASSOCIATION D'ENSEIGNEMENT MEDICAL DES HOPITAUX DE PARIS 1966; 42:2970-4. [PMID: 4292625] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
|
48
|
Retinoblastoma, megavoltage, therapy and unilateral disease. TRANSACTIONS - AMERICAN ACADEMY OF OPHTHALMOLOGY AND OTOLARYNGOLOGY. AMERICAN ACADEMY OF OPHTHALMOLOGY AND OTOLARYNGOLOGY 1966; 70:944-50. [PMID: 4961614] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
|
49
|
Antianginal drugs. IV. The long-acting nitrates. Am Heart J 1966; 71:712-713. [PMID: 5935864 DOI: 10.1016/0002-8703(66)90324-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 05/21/2023]
|
50
|
Myeloid leukemia C-1498 as a screen for cancer chemotherapeutic agents. Cancer Res 1966; 26:375-90. [PMID: 4223140] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
|